Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis

Daniel A. Goldstein, Qiushi Chen, Turgay Ayer, Kelvin K.W. Chan, Kiran Virik, Ariel Hammerman, Baruch Brenner, Christopher R. Flowers, Peter S. Hall

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint Dive into the research topics of 'Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences